Opus Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-55,700
Closed -$3.58M 95
2019
Q4
$3.58M Hold
55,700
0.59% 57
2019
Q3
$2.83M Hold
55,700
0.49% 68
2019
Q2
$2.53M Hold
55,700
0.48% 66
2019
Q1
$2.66M Hold
55,700
0.53% 60
2018
Q4
$2.9M Hold
55,700
0.62% 50
2018
Q3
$3.46M Hold
55,700
0.6% 53
2018
Q2
$3.08M Buy
55,700
+11,700
+27% +$632K 0.56% 54
2018
Q1
$2.78M Hold
44,000
0.51% 54
2017
Q4
$2.7M Hold
44,000
0.48% 55
2017
Q3
$2.81M Hold
44,000
0.51% 58
2017
Q2
$2.45M Hold
44,000
0.42% 62
2017
Q1
$2.39M Buy
44,000
+11,000
+33% +$603K 0.41% 67
2016
Q4
$1.93M Buy
33,000
+18,000
+120% +$984K 0.34% 69
2016
Q3
$809K Buy
+15,000
New +$964K 0.14% 79
2016
Q1
Sell
-5,000
Closed -$344K 74
2015
Q4
$344K Hold
5,000
0.06% 77
2015
Q3
$296K Hold
5,000
0.06% 78
2015
Q2
$333K Hold
5,000
0.06% 79
2015
Q1
$323K Hold
5,000
0.06% 79
2014
Q4
$295K Sell
5,000
-18,866
-79% -$1.06M 0.05% 79
2014
Q3
$1.22M Sell
23,866
-10,000
-30% -$500K 0.23% 74
2014
Q2
$1.64M Sell
33,866
-5,000
-13% -$246K 0.32% 70
2014
Q1
$2.02M Hold
38,866
0.46% 66
2013
Q4
$2.07M Sell
38,866
-54,038
-58% -$2.75M 0.56% 60
2013
Q3
$4.3M Hold
92,904
0.98% 19
2013
Q2
$4.15M Buy
+92,904
New +$4.03M 0.99% 36

Other funds holding BMY

Opus Investment Management's BMY Position: Q1 2020 in Review

Opus Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 55,700 shares — an estimated $3.58M sold.

Opus Investment Management first reported a position in BMY in Q2 2013 and held it in 25 quarters. The position peaked at $4.3M in Q3 2013. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Opus Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • Opus Investment Management sold 55,700 Bristol-Myers Squibb shares in Q1 2020, an estimated $3.58M.
  • Opus Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 25 quarters.
  • Opus Investment Management's Bristol-Myers Squibb position peaked at $4.3M in Q3 2013.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Opus Investment Management's 13F filing for Q1 2020, filed 14 May 2020.